Promising pharmaceutical agents emerge as sports doping products Nov 19, 2009
SARMs represent a promising class of therapeutics for the treatment of various diseases such as sarcopenia, osteoporosis, benign prostatic hyperplasia (BPH), and cancer cachexia. While none of these agents have yet been approved for therapeutic use, SARMs are gaining popularity in the sports doping community because they are believed to provide the benefits of traditional anabolic/androgenic steroids such as testosterone with fewer unwanted side effects. (EurekAlert!)
Therapeutic Value of Reishi Nov 1, 2009
g., prostatic hyperplasia, or BPH). (Noguchi M, et al. Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms. (Suite101.com)
House calls: Know Your Stats Sep 18, 2009
Prostate cancer and benign prostatic hyperplasia (BPH) an enlarged prostate which can lead to lower urinary tract symptoms are two concerns that can affect a man s quality of life, and should be discussed with a physician. The new campaign, Know Your Stats, features a comprehensive web and media campaign featuring NFL players past and present. (Kingston Mariner, MA)
Mandelson Admitted to Hospital for Prostate Operation, Will Stay Overnight Aug 22, 2009
The condition, known as or BPH, develops in about half of men in their sixties and as many as 90 percent of those in their seventies and eighties, studies show. Prostate cancer was the most common malignancy in U.S. men last year with 186,320 new cases, and the second-highest killer among cancers with 28,660 deaths, according to the American Cancer Society in Atlanta. (Bloomberg -- UK)
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia Aug 17, 2009
QUEBEC CITY, Aug. 17 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for urology, cetrorelix pamoate. As announced on March 6, 2009, sanofi-aventis U.S. LLC entered into an agreement with AEterna Zentaris... (PR Newswire)
Patients With Lower Urinary Tract Symptoms More Likely To Suffer From Metabolic Syndrome Jul 5, 2009
What they may not know is that the disease known as BPH (benign. . (Science Daily)
Painkillers May Prevent Prostate Problems Jun 26, 2009
Such enlargement, called benign prostatic hyperplasia or BPH, is common in men over forty, affecting about 50 percent of men by age 50, and about 75 percent by age 80. The other study was led by Dr. Eric A. Singer, who is chief resident in urology at the University of Rochester Medical Center in New York. (Newsmax)
Oregon Recreation Report (3) Jun 24, 2009
3% from the previous year but success (birds per hunter or bph) was down -26. 3. (Lebanon Express, OR)
Consumer Reports 'Best Buy Drug' for Enlarged Prostate Could Save Consumers Nearly $3,000 a Year Jun 16, 2009
Almost all men -- if they reach a certain age -- will develop an enlarged prostate, also known as Benign Prostatic Hypertrophy, or BPH. The statistics are not precise, but about half of men of any age who have BPH will have symptoms that require attention and treatment that may involve taking one of the drugs evaluated in the report. "This means that millions of men over the age of 50 are regularly taking drugs or using other treatment options to ease the symptoms of BPH," says Santa. (PR Newswire)
Drug For Urination Difficulties Linked With Complications After Cataract Surgery May 26, 2009
Benign prostatic hyperplasia (BPH; enlarged prostate) affects nearly 3 of 4 men by the age of 70 years, with symptoms of BPH including urination difficulties. A commonly prescribed medication for BPH is tamsulosin, which accounted for more than 1 billion in sales in 2007, according to background information in the article. (Science Daily)
Study Reiterates Eye Risks Linked to Flomax May 21, 2009
Flomax is often prescribed to treat an enlarged prostate, a condition known as benign prostatic hyperplasia, or BPH, which affects almost three of four men 70 and older. Symptoms include difficulty urinating. (MEDLINEplus)
Urologists undertake outreach programme at Sunyani Hospital May 20, 2009
"The management of commonest diseases like symptomatic BPH and Ca of prostrate have seen a phase of transformation from traditional open surgery to endoscopic surgery", he said. "The introduction of laparoscopy in the management of localised Ca of the prostate, followed by robotic surgery in the urologic armamentarium has resulted in major changes in our daily surgical practices". (Ghana Web, Ghana)
Protox reports 2009 first quarter results May 15, 2009
"During the first quarter we made significant progress in advancing our lead drug, PRX302, for the treatment of moderate to severe BPH," said Dr. Fahar Merchant, President and CEO of Protox. "Executing the placebo controlled BPH study, TRIUMPH, in a timely fashion is our primary goal and we expect to announce top-line results from this study before the end of this year." 2009 Q1 Highlights - Commenced enrollment of a multi-centre, double-blinded, placebo controlled Phase 2 study of PRX302 (study... (Canada Newswire)
Exploding Bubbles Trim The Prostate Apr 29, 2009
Roberts hopes to develop histotripsy into a clinical treatment for early-stage cancer and enlarged prostate (BPH). The talk "Histotripsy: Urologic applications" by William Roberts will be presented at the 157th Acoustical Society of America Meeting to be held May 18-22 in Portland, Ore. (Science Daily)
Urodynamix Receives Financial Contribution From NRC-IRAP to Support Development of NIRS Technology to Improve the Minimally Invasive Treatment (MIT) of Benign Prostatic Hypertrophy (BPH) Apr 28, 2009
This technology is expected to significantly improve the efficacy of the minimally invasive treatment (MIT) of benign prostatic hypertrophy (BPH) and in turn lead to growth in the number of MIT procedures. MIT is used for the treatment of lower urinary tract symptoms (LUTS) due to BPH in men ... Transurethral microwave thermotherapy treatment (TUMT) and other clinically available MIT procedures including transurethral needle ablation (TUNA) and transrectal high intensity focused ultrasound... (CCNMatthews Press Releases)
Nature Reviews Urology (formerly Nature Clinical Practice Urology) Apr 8, 2009
Home : Nature Reviews Urology. Nature Reviews Urology. (Nature News Service)
Don't discard the PSA test for cancer yet Mar 30, 2009
Instead of abandoning PSA screening altogether, we must use an elevated PSA as an early indicator of one of three prostate conditions (BPH, prostatitis and prostate cancer) that can be ultimately identified by the medical detective process described above: one that uses a much broader set of information. What we need now is for more members of the medical community to think like Dr. House. (San Francisco Chronicle -- Opinion)
Neurocrine Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry Conference Mar 25, 2009
Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at. (PR Newswire)
School kids to be offered vaccines Feb 19, 2009
The goal is to begin offering the shots when kids return from February vacation next week, said BPH spokeswoman Ann Scales. We ve had a tragic loss of a child, Scales said. (Boston Herald)
Botox Relieves Benign Prostatic Hyperplasia Symptoms Feb 12, 2009
MedlinePlus: Botox relieves BPH symptoms ... Botox relieves BPH symptoms ... Dr. Giuseppe Brisinda of Catholic University Hospital "Agostino Gemelli" in Rome and his colleagues report the outcomes for 77 men ages 50-80 years with so-called benign prostatic hypertrophy or BPH, in the medical journal Urology. (MEDLINEplus)
International Journal of Impotence Research Feb 8, 2009
Assessing BPH. Understanding BPH risk factors and pathology help clarify the best therapeutic strategies for the disease. how self-administered questionnaires, combination therapy and managing a patient's PSA can lead to a happier, healthier patient. (Nature News Service)
Large Prostates Removed with Single-Keyhole Surgery Feb 7, 2009
NEW YORK (Reuters Health) - An enlarged prostate due to benign prostatic hyperplasia, or BPH, can be safely and effectively removed using a type of minimally invasive single-keyhole surgery, researchers report ... In the medical journal Urology, Desai and colleagues report their initial experience with STEP performed through a single incision in three patients suffering from bothersome BPH symptoms, which may include frequent and sometimes painful urination. (MEDLINEplus)
